When it comes to embracing new tech, our Little Red Dot isn't just keeping up with the future — we're zooming ahead. Case in ...

Antibody–siRNA conjugates (ARCs) are a type of promising drug modalities for cancer therapy. However, initial reports of ARCs present the gene knockdown effect only in limited tissues (e.g., muscles) ...